Jane Zhu, M.D. comments on a research study that suggests Medicaid patients have less access, longer wait times for dermatologists.

Scientists at the Oregon National Primate Research Center have uncovered new clues implicating a type of herpes virus as the cause of a central nervous system disorder similar to multiple sclerosis in people.

Research from OHSU’s program to develop a Physician Order for Life-Sustaining Treatment, or POLST, is referenced by The New York Times.

Story highlights OHSU’s COVID Capacity Center to track hospital capacity statewide.

Antwon Chavis, M.D., is featured in Zoom interview with Gov. Kate Brown during her annual State of the State address.

Lisa Coussens, Ph.D., is appointed to the scientific advisory board of HiberCell.

In a story about a Portland area resident who says they experienced a minor delayed allergic reaction from a COVID vaccination, an OHSU spokesperson is quoted as saying “while allergic reactions can be uncomfortable, it’s up to each individual to weigh the risk of a possible allergic reaction against the risk of serious illness due to COVID-19 infection, in consultation with their primary care provider or specialist as appropriate.”

In a story about new research highlighting inaccurate results among patients with darker skin tones monitored with a pulse oximeter, Gopal Allada, M.D., says, “It triggers a lot of conversations within people who use the tool.”

In a story about how to convince more people to get a COVID vaccine when they can, David Bangsberg, M.Sc., M.D., M.P.H., notes low vaccination rates recently caused measles outbreaks in Oregon.

OHSU issues a statement, which starts with “OHSU and has been from the beginning, a strong advocate for broad, efficient vaccine distribution to those with the greatest need, including community providers and vulnerable populations.”